share_log
Reuters ·  Aug 15 16:30
Incyte:Expects to File Supplemental Biologics License Application for Tafasitamab in Combination With Lenalidomide and Rituximab in Fl by End of Year
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment